Every vaccine maker was asked to make their doses in Canada and all said no: Anand
OTTAWA -- Procurement Minister Anita Anand says every COVID-19 vaccine maker Canada signed a contract with last summer was asked if they could make the doses in Canada and all of them concluded they could not.
Anand is appearing before a House of Commons committee studying Canada's domestic production capacity for COVID-19 vaccines today.
She says all the manufacturers studied what was possible in Canada for production and the existing biomanufacturing facilities were not suitable.
Canada signed contracts for seven vaccines between the end of July and the end of October and most of them are being made in Europe.
Prime Minister Justin Trudeau announced earlier this week Canada has a new contract with Maryland-based Novavax to eventually make doses of its vaccine at a new National Research Council facility going up in Montreal.
But that building won't be finished until the summer and the new doses are not likely to start being pumped out until late fall at the earliest, long after Canada expects to import enough doses to vaccinate the entire population.
Mia Rabson, The Canadian Press
- Canada to get up to 1.1 m more doses by March through global vaccine alliance
- First doses of Pfizer COVID-19 vaccine, not yet approved, to land in Canada next week
- Canada signs deal with Novovax to get 76 million doses of COVID-19 vaccine
- Canada probing whether delaying second COVID-19 vaccine doses could help more people
- Deliveries of COVID-19 vaccine doses to Canada set to more than quadruple next week
- Mass COVID-19 vaccination clinic opens in Mississauga
- Pearson Airport in Mississauga welcome 19 international and 13 domestic flights with COVID-19
- International travelers are walking out of Mississauga's Pearson Airport and ignoring quarantine rules
- Mississauga residents 80 and older can now book their vaccines
- Region of Peel calls flyer asking Mississauga parents to completely isolate their COVID-positive children a “mistake”